Clinical Trials Directory

Trials / Unknown

UnknownNCT04015791

NOCISCAN-Lumbar Spine (LS) Clinical Evaluation Study

Clinical Evaluation of NOCISCAN-Lumbar Spine (LS) Disc MR Spectroscopy (MRS) for Diagnosis of Discogenic Low Back Pain and Correlation With Surgical Outcomes

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Nocimed, LLC · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

A prospective, double blinded, multi-center study to assess the validity and clinical utility of the pre-operative NOCISCAN-LS software in the identification of painful lumbar discs, and the correlation with improved surgical outcomes at 3, 6, 12 and 24 months (follow-up) following spine surgery in a single enrollment arm of subjects with chronic symptomatic single level degenerative disc disease (DDD) at L3 to S1, but with two evaluation groups- Match Group and Miss Group,of subjects based on the association between the NOCISCORE results of treated and untreated disc levels.

Conditions

Interventions

TypeNameDescription
OTHERNOCISCAN-LS Disc MR SpectroscopyThe investigational Nociscan Suite is a software suite that works with existing high field MR systems and MRS pulse sequence via and optimized protocol to conduct MRS exam of lumbar discs. The software suite post-processes the NOCISCAN-LS disc MRS exam data to calculate ratios of spectroscopic signals at regions along the MRS frequency spectrum associated with certain chemicals that change with degeneration and pain

Timeline

Start date
2023-04-01
Primary completion
2024-09-30
Completion
2025-12-31
First posted
2019-07-11
Last updated
2022-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04015791. Inclusion in this directory is not an endorsement.